Battle Ceri, Hutchings Hayley, Lovett Simon, Bouamra Omar, Jones Sally, Sen Aruni, Gagg James, Robinson David, Hartford-Beynon Jake, Williams Jeremy, Evans Adrian
Crit Care. 2014 May 14;18(3):R98. doi: 10.1186/cc13873.
Blunt chest wall trauma accounts for over 15% of all trauma admissions to Emergency Departments worldwide. Reported mortality rates vary between 4 and 60%. Management of this patient group is challenging as a result of the delayed on-set of complications. The aim of this study was to develop and validate a prognostic model that can be used to assist in the management of blunt chest wall trauma.
There were two distinct phases to the overall study; the development and the validation phases. In the first study phase, the prognostic model was developed through the retrospective analysis of all blunt chest wall trauma patients (n = 274) presenting to the Emergency Department of a regional trauma centre in Wales (2009 to 2011). Multivariable logistic regression was used to develop the model and identify the significant predictors for the development of complications. The model's accuracy and predictive capabilities were assessed. In the second study phase, external validation of the model was completed in a multi-centre prospective study (n = 237) in 2012. The model's accuracy and predictive capabilities were re-assessed for the validation sample. A risk score was developed for use in the clinical setting.
Significant predictors of the development of complications were age, number of rib fractures, chronic lung disease, use of pre-injury anticoagulants and oxygen saturation levels. The final model demonstrated an excellent c-index of 0.96 (95% confidence intervals: 0.93 to 0.98).
In our two phase study, we have developed and validated a prognostic model that can be used to assist in the management of blunt chest wall trauma patients. The final risk score provides the clinician with the probability of the development of complications for each individual patient.
钝性胸壁创伤占全球急诊室所有创伤入院病例的15%以上。报告的死亡率在4%至60%之间。由于并发症的延迟发生,对这一患者群体的管理具有挑战性。本研究的目的是开发并验证一种可用于协助管理钝性胸壁创伤的预后模型。
整个研究分为两个不同阶段;开发阶段和验证阶段。在第一个研究阶段,通过对威尔士一家地区创伤中心急诊科(2009年至2011年)收治的所有钝性胸壁创伤患者(n = 274)进行回顾性分析来开发预后模型。使用多变量逻辑回归来开发模型并确定并发症发生的显著预测因素。评估模型的准确性和预测能力。在第二个研究阶段,2012年在一项多中心前瞻性研究(n = 237)中完成了模型的外部验证。对验证样本重新评估模型的准确性和预测能力。开发了一个风险评分用于临床环境。
并发症发生的显著预测因素为年龄、肋骨骨折数量、慢性肺病、受伤前使用抗凝剂以及血氧饱和度水平。最终模型显示出出色的c指数为0.96(95%置信区间:0.93至)。
在我们的两阶段研究中,我们开发并验证了一种可用于协助管理钝性胸壁创伤患者的预后模型。最终风险评分为临床医生提供了每位患者发生并发症的概率。 98)